Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesGoodrx Holdings Inc

Goodrx Holdings Inc

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
3.475 USD -0.17 ( 4.79%)
Last update at 2026-11-12T15:40:00Z
VOLUME
74495
Market Cap
1190.60M
P/E
58.17

Momentum Score

…

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.47
Low
3.64
High
52 Week Price Range
1.77
Low
5.81
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

GoodRx Holdings operates a digital marketplace for prescription drug price comparison and offers telehealth and subscription services. Long-term growth may be supported by persistent high drug prices, wider adoption of digital health and expansion of advertising and subscription revenue. Investors may find the company attractive because of its large consumer audience, recognizable brand and diversified monetization channels.
Material risks include regulatory or reimbursement changes that could reduce pharmacy or PBM fee income, rising competition from insurers and PBMs, and execution or data-privacy failures that could weaken user engagement.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.65
Dividend Yield
-
Revenue TTM
785.23M
Revenue Per Share
2.29
Gross Profit TTM
713.19M
Debt / Equity
0.10
ROE
2.52%
Net Debt
-202.28M
ROCE
8.56%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 56.54M 31.46M -55.57M -23.23M -10.18M
Net income 30.44M 16.39M -8.87M -32.83M -25.25M
Selling general administrative 113.96M 117.86M 125.52M 144.79M 154.69M
Selling and marketing expenses 331.56M 367.11M 341.33M 357.63M 370.22M
Gross profit 654.13M 744.11M 683.34M 701.48M 698.71M
Reconciled depreciation 85.22M 69.54M 79.59M 54.18M 34.54M
Ebit 99.14M 84.38M 1.16M 11.01M 13.41M
Ebitda 184.36M 153.92M 108.82M 65.19M 48.00M
Depreciation and amortization 85.22M 69.54M 107.67M 54.18M 34.60M
Non operating income net other - - - 9.27M 0.06M
Operating income 106.97M 65.85M -27.01M 11.01M 13.41M
Other operating expenses 689.88M 726.48M 777.27M 764.82M 732.02M
Interest expense 42.60M 52.92M 56.73M 34.24M 23.64M
Tax provision 26.10M 15.07M -50.71M 9.60M 15.08M
Interest income 10.93M 23.27M 29.14M 9.27M 0.06M
Net interest income -31.67M -29.65M -24.69M -24.97M -23.58M
Income tax expense -26.10M 15.07M -46.70M 9.60M 15.08M
Total revenue 796.85M 792.32M 750.26M 766.55M 745.42M
Total operating expenses 547.16M 678.26M 710.35M 699.74M 685.30M
Cost of revenue 142.72M 48.22M 66.92M 65.08M 46.72M
Total other income expense net -50.43M -34.39M -28.57M -34.24M -23.58M
Net income from continuing ops 30.44M 16.39M 15.03M -32.83M -25.25M
Net income applicable to common shares - - - -32.83M -25.25M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1404.06M 1388.07M 1588.80M 1604.63M 1607.62M
Intangible assets 64.08M 176.88M 156.34M 189.94M 133.78M
Other current assets 145.54M 50.08M 40.45M 45.38M 29.64M
Total liab 787.80M 663.41M 826.84M 789.80M 775.95M
Total stockholder equity 616.26M 724.66M 761.96M 814.83M 831.68M
Other current liab 216.84M 97.67M 64.22M 39.64M 43.86M
Common stock 0.03M 0.04M 0.04M 0.04M 0.04M
Capital stock 0.03M 0.04M 0.04M 0.04M 0.04M
Retained earnings -1410.57M -1441.01M -1457.40M -1448.54M -1415.71M
Other liab - - - 7.56M 5.38M
Good will 430.33M 410.77M 410.77M 412.12M 329.70M
Other assets - - - 8.16M 6.01M
Cash 261.82M 448.35M 672.30M 757.16M 941.11M
Total current liabilities 246.00M 123.90M 122.56M 76.32M 81.11M
Current deferred revenue - - 7.11M 7.88M 6.87M
Net debt -202.28M 95.04M 38.77M -40.14M -238.78M
Short term debt 9.75M 10.64M 14.96M 11.10M 12.88M
Short long term debt 5.00M 5.00M 8.79M 7.03M 7.03M
Short long term debt total 59.54M 543.39M 711.07M 717.02M 702.33M
Other stockholder equity 2026.80M 2165.63M 2219.32M 2263.32M 2247.35M
Property plant equipment - - - 19.82M 21.61M
Total current assets 643.10M 659.25M 872.79M 919.69M 1088.83M
Net tangible assets - - - 814.83M 831.68M
Net receivables 235.75M 160.83M 160.04M 117.14M 126.41M
Long term debt 483.26M 486.71M 647.70M 651.80M 655.86M
Inventory - - 0.00M - -8.33M
Accounts payable 19.41M 14.14M 36.27M 17.70M 17.50M
Accumulated other comprehensive income - - 0.00M - -
Common stock total equity - - - 0.04M 0.04M
Retained earnings total equity - - - -1448.54M -1415.71M
Non currrent assets other 168.36M 8.52M 22.77M 27.16M 6.01M
Non current assets total 760.96M 728.81M 716.01M 684.95M 518.80M
Capital lease obligations 54.54M 51.68M 54.58M 58.20M 39.44M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -70.35M -41.61M -210.50M -178.73M
Change to liabilities - - - -4.02M 17.50M
Total cashflows from investing activities -119.96M -70.35M -55.77M -210.50M -178.73M
Net borrowings -5.00M -167.00M -5.27M -7.03M -7.03M
Total cash from financing activities -234.47M -337.50M -167.40M -120.23M -30.53M
Change to operating activities - - - -20.79M 27.95M
Net income 25.01M 16.39M -8.87M -32.83M -25.25M
Change in cash -186.53M -223.95M -84.87M -183.94M -30.48M
Begin period cash flow 448.35M 672.30M 757.16M 941.11M 971.59M
End period cash flow 261.82M 448.35M 672.30M 757.16M 941.11M
Total cash from operating activities 167.90M 183.89M 138.29M 146.78M 178.78M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 81.68M 69.54M 111.77M 54.18M 34.54M
Other cashflows from investing activities -87.68M -70.35M -54.72M -206.53M -174.16M
Dividends paid - - 0.00M - -
Change to account receivables -88.02M -2.33M -26.47M 1.38M -43.95M
Sale purchase of stock -206.94M -158.84M -103.97M -101.72M 35.02M
Other cashflows from financing activities -23.78M -11.64M -58.15M -20.64M -23.50M
Change to netincome - - - 126.39M 173.31M
Capital expenditures 3.52M 70.35M 55.77M 55.21M 34.46M
Change receivables - - - 1.38M -43.95M
Cash flows other operating - - - -1.73M -14.93M
Cash and cash equivalents changes - - - -183.94M -30.48M
Change in working capital -56.44M 2.09M -21.94M -20.29M -11.80M
Stock based compensation 58.66M 99.03M 104.82M 120.23M 160.46M
Other non cash items 59.00M 8.76M 18.07M 25.98M 7.98M
Free cash flow 164.38M 113.55M 82.53M 91.57M 144.32M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GDRX
Goodrx Holdings Inc		 -0.17
4.79%		 3.48 58.17 10.29 1.52 1.88 1.86 8.53
VEEV
Veeva Systems Inc Class A		 -4.88
1.60%		 299.89 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited		 0.68
0.48%		 142.50 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock		 -4.81
6.06%		 74.62 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc		 -0.07
1.22%		 5.66 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Goodrx Holdings Inc

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

2701 Olympic Boulevard, Santa Monica, CA, United States, 90404

855 268 2822

https://www.goodrx.com

697

Name Title Year Born
Mr. Douglas Joseph Hirsch Co-founder, Co-CEO & Director 1971
Mr. Trevor Bezdek Co-founder, Co-CEO, Sec. & Director 1978
Mr. Karsten Ian Voermann CFO & Principal Financial Officer 1970
Mr. Babak Azad Chief Marketing Officer and SVP of Marketing & Communications 1973
Mr. Bansi Nagji Pres of Healthcare 1965
Mr. Raj Beri Chief Operating Officer NA
Mr. Romin Nabiey Chief Accounting Officer & Principal Accounting Officer 1987
Ms. Whitney Notaro VP of Investor Relations NA
Ms. Vina M. Leite Chief People Officer 1969
Mr. Justin Fengler Sr. VP of Corp. Strategy & Bus. Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…